Rebamipide suppliers

Rebamipide

CAS:: 90098-04-7

MF:: C19H15ClN2O4

MW:: 370.79

SecurityInformation

Symbol(GHS) ：: GHS06

Signal word ：: Danger

Hazard statements ：: H301

Precautionary statements ：: P301+P310

PPE：: Eyeshields, Faceshields, Gloves, type N95 (US)

RIDADR ：: UN 2811 6.1 / PGIII

WGK Germany ：: 3

RTECS ：: VC2518500

HS Code ：: 29337900

Storage Class：: 6.1C - Combustible acute toxic Cat.3
toxic compounds or compounds which causing chronic effects

Hazard Classifications：: Acute Tox. 3 Oral

Use：: Rebamipide, a gastroprotective drug, was developed in Japan and was proven to be superior to cetraxate, the former most prescribed drug of the same category, in 1989 in the treatment for gastric ulcers. The initially discovered basic mechanisms of action of rebamipide included its action as a prostaglandin inducer and oxygen free-radical scavenger. In the last 5 years, several basic and clinical studies have been performed for functional dyspepsia, chronic gastritis, NSAID-induced gastrointestinal injuries, gastric ulcer following eradication therapy for Helicobacter pylori, gastric ulcer after endoscopic surgery and ulcerative colitis. In addition, several molecules have been identified as therapeutic targets of rebamipide to explain its pleiotropic pharmacological actions.

More▼

You can find Rebamipide suppliers, manufacturers, and distributors from countries such as CHINA, United States and the India here. Browse to the tetrahydrofuran product information displayed by the supplier, as well as the supplier's contact and capability information.

Wuhan Fortuna Chemical Co., Ltd